Avantor Gross Profit 2018-2025 | AVTR

Avantor annual/quarterly gross profit history and growth rate from 2018 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Avantor gross profit for the quarter ending March 31, 2025 was $0.535B, a 6.24% decline year-over-year.
  • Avantor gross profit for the twelve months ending March 31, 2025 was $2.244B, a 2.85% decline year-over-year.
  • Avantor annual gross profit for 2024 was $2.279B, a 3.57% decline from 2023.
  • Avantor annual gross profit for 2023 was $2.364B, a 9.18% decline from 2022.
  • Avantor annual gross profit for 2022 was $2.603B, a 4% increase from 2021.
Avantor Annual Gross Profit
(Millions of US $)
2024 $2,279
2023 $2,364
2022 $2,603
2021 $2,503
2020 $2,081
2019 $1,921
2018 $1,820
2017 $433
Avantor Quarterly Gross Profit
(Millions of US $)
2025-03-31 $535
2024-12-31 $563
2024-09-30 $564
2024-06-30 $582
2024-03-31 $571
2023-12-31 $570
2023-09-30 $579
2023-06-30 $590
2023-03-31 $625
2022-12-31 $615
2022-09-30 $651
2022-06-30 $648
2022-03-31 $690
2021-12-31 $648
2021-09-30 $616
2021-06-30 $627
2021-03-31 $613
2020-12-31 $582
2020-09-30 $506
2020-06-30 $491
2020-03-31 $502
2019-12-31 $480
2019-09-30 $474
2019-06-30 $491
2019-03-31 $475
2018-12-31
2018-09-30 $479
2018-06-30 $468
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $8.872B $6.784B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.913B 25.22
CVS Health (CVS) United States $77.267B 9.60
Elevance Health (ELV) United States $63.437B 8.53
Cencora (COR) United States $56.784B 19.75
DiDi Global (DIDIY) China $26.545B 28.20
Labcorp Holdings (LH) United States $21.098B 17.11
Natera (NTRA) United States $19.106B 0.00
BioMerieux (BMXMF) France $15.985B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.371B 0.00
Medpace Holdings (MEDP) United States $13.731B 35.52
CochLear (CHEOY) Australia $13.060B 0.00
ICON (ICLR) Ireland $13.042B 12.12
Solventum (SOLV) United States $12.616B 13.35
Revvity (RVTY) United States $11.331B 19.50
Viatris (VTRS) United States $10.845B 3.73
Sonic Healthcare (SKHHY) Australia $8.965B 0.00
HealthEquity (HQY) United States $8.424B 36.90
Charles River Laboratories (CRL) United States $8.024B 15.72
Caris Life Sciences,�Inc (CAI) United States $7.706B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.059B 29.79
BrightSpring Health Services (BTSG) United States $3.542B 32.50
Sotera Health (SHC) United States $3.225B 18.32
Surgery Partners (SGRY) United States $2.827B 36.77
Organon (OGN) United States $2.553B 2.71
Concentras Parent (CON) United States $2.534B 14.64
Alignment Healthcare (ALHC) United States $2.441B 0.00
GeneDx Holdings (WGS) United States $2.308B 88.90
Progyny (PGNY) United States $1.970B 43.36
GoodRx Holdings (GDRX) United States $1.757B 35.14
PACS (PACS) United States $1.750B 0.00
Premier (PINC) United States $1.738B 13.19
Ardent Health (ARDT) United States $1.503B 6.41
Teladoc Health (TDOC) United States $1.477B 0.00
Establishment Labs Holdings (ESTA) $1.257B 0.00
Pediatrix Medical (MD) United States $1.094B 8.33
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
AMN Healthcare Services Inc (AMN) United States $0.763B 7.14
CareDx (CDNA) United States $0.725B 11.32
Embecta (EMBC) United States $0.625B 4.21
Nutex Health (NUTX) United States $0.556B 8.41
So-Young (SY) China $0.541B 0.00
InnovAge Holding (INNV) United States $0.524B 0.00
SBC Medicals (SBC) United States $0.516B 0.00
Omada Health (OMDA) $0.495B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
LifeMD (LFMD) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.414B 0.00
Enhabit (EHAB) United States $0.342B 28.17
Oncology Institute (TOI) United States $0.316B 0.00
Performant Healthcare (PHLT) United States $0.287B 0.00
Beauty Health (SKIN) United States $0.231B 0.00
DocGo (DCGO) United States $0.149B 24.33
Pheton Holdings (PTHL) China $0.148B 0.00
Sera Prognostics (SERA) United States $0.109B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
KindlyMD (NAKA) United States $0.067B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.051B 0.00
ModivCare (MODV) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.016B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00